Drugs / BUTAMIRATE
BUTAMIRATE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05182047 | Mar → May 2022 | — | McNeil AB | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BUTAMIRATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1332546 ↗ |
| Known as | ABBOTT 36581 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1332546 ↗ |
| Known as | Butamirate citrate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05182047 ↗ |
| Known as | Butamirato | ChEMBL registry synonym — accepted as the source's own label CHEMBL1332546 ↗ |
| Known as | Butamyrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1332546 ↗ |
| Known as | Codimin | ChEMBL registry synonym — accepted as the source's own label CHEMBL1332546 ↗ |
| Known as | HH 197 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1332546 ↗ |
| Modality | Small molecule | — CHEMBL1332546 ↗ |